Pulmonary Cell News Volume 11.07 | Feb 24 2022

    0
    14







    2022-02-24 | PULCN 11.07


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 11.07 – 24 February, 2022
    TOP STORY

    Targeting Polarized Phenotype of Microglia via IL6/JAK2/STAT3 Signaling to Reduce NSCLC Brain Metastasis

    Scientists indicated that targeting IL6/JAK2/STAT3 signaling in activated microglia may be a promising new approach for inhibiting brain metastasis in NSCLC patients.
    [Signal Transduction and Targeted Therapy]

    Full Article
    Stay current with COVID-19 research. Read Immunology of Infectious Disease News now.
    PUBLICATIONSRanked by the impact factor of the journal

    MG53 Attenuates Nitrogen Mustard-Induced Acute Lung Injury

    Exposure of lung epithelial and endothelial cells to nitrogen mustard led to intracellular oxidative stress that compromised the intrinsic cell membrane repair function of MG53.
    [Journal of Cellular and Molecular Medicine]

    Full Article

    PD-L1 Mediates Lung Fibroblast to Myofibroblast Transition through Smad3 and β-Catenin Signaling Pathways

    Researchers demonstrated that fibroblast programmed death ligand-1 (PD-L1) may have promoted pulmonary fibrosis through both Smad3 and β-catenin signaling and may represent a novel interventional target for idiopathic pulmonary fibrosis.
    [Scientific Reports]

    Full Article

    Therapeutic Targeting of BAP1/ASXL3 Sub-complex in ASCL1-Dependent Small Cell Lung Cancer

    Scientists investigated the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small cell lung cancer by developing a next-generation BAP1 inhibitor.
    [Oncogene]

    Full Article

    TUSC2 Immunogene Enhances Efficacy of Chemo-Immuno Combination on KRAS/LKB1 Mutant NSCLC in Humanized Mouse Model

    Researchers used a humanized mouse model to show that while carboplatin plus pembrolizumab reduced tumor growth moderately and transiently, the addition of the tumor suppressor gene TUSC2, delivered systemically in nanovesicles, to this combination, eradicated tumors in the majority of animals.
    [Communications Biology]

    Full Article

    Ibrutinib Reverses IL-6-Induced Osimertinib Resistance through Inhibition of Laminin α5/FAK Signaling

    The authors showed that clinically, plasma interleukin-6 (IL-6) level predicted osimertinib efficacy in epidermal growth factor receptor mutant NSCLC patients.
    [Communications Biology]

    Full Article

    Biomarker LEPRE1 Induces Pelitinib-Specific Drug Responsiveness by Regulating ABCG2 Expression and Tumor Transition States in Human Leukemia and Lung Cancer

    Investigators discovered a mechanical correlation between leucine proline-enriched proteoglycan 1 (LEPRE1) and pelitinib drug sensitivity using in silico statistical methods and confirmed the correlation in acute myeloid leukemia and A549 lung cancer cells.
    [Scientific Reports]

    Full Article

    Quercitrin Restrains the Growth and Invasion of Lung Adenocarcinoma Cells by Regulating Gap Junction Protein Beta 2

    Quercitrin prohibited the cell viability and clone-formation of lung adenocarcinoma (LUAD) cells in vitro. Quercitrin treatment reduced the aggressive phenotypes in LUAD cells.
    [Bioengineered]

    Full ArticleGraphical Abstract

    Circular RNA-UBE2D2 Accelerates the Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells via Modulating microRNA-376a-3p/Eukaryotic Translation Initiation Factor 4γ2 Axis

    Investigators suggested that circ-UBE2D2 promoted the proliferation, migration and invasion but restrained apoptosis of lung cancer cells by regulating miR-376a-3p/eukaryotic translation initiation factor 4γ2 axis.
    [Bioengineered]

    Full Article
    Studying COVID-19 with ALI culture
    REVIEWS

    Targeting the Epigenetic Processes to Enhance Antitumor Immunity in Small Cell Lung Cancer

    Scientists review current clinical trials of epigenetic therapy against small cell lung cancer and the mechanisms of epigenetic inhibitors to boost antitumor immunity.
    [Seminars in Cancer Biology]

    Full Article

    Emerging Function and Clinical Significance of Extracellular Vesicle Noncoding RNAs in Lung Cancer

    The authors summarize the biological characteristics and functions of extracellular vesicles ncRNAs in the biological processes of lung cancer (LC), focusing on their potential to serve as diagnostic and prognostic biomarkers of LC as well as their probable role in the clinical treatment of LC.
    [Molecular Therapy Oncolytics]

    AbstractFull ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Center Clinical Trial

    Mauna Kea Technologies announced that, as part of its collaboration with the Lung Cancer Initiative (LCI) at Johnson & Johnson, initial enrollment of patients has begun in a prospective, multi-center, open-label, single-arm clinical feasibility study sponsored by LCI.
    [Mauna Kea Technologies]

    Press Release

    European Commission Approves TEPMETKO® (Tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations

    Merck KGaA, announced that the European Commission has approved once-daily oral TEPMETKO® (tepotinib) as monotherapy for the treatment of adult patients with advanced NSCLC harboring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (METex14) skipping.
    [Merck KGaA]

    Press Release
    FEATURED EVENT

    EHA-SWG Scientific Meeting

    April 7 – April 9
    Rome, Italy & Virtual

    > See All Events

    JOB OPPORTUNITIES

    Researcher – Cancer Biology

    BC Cancer Research Institute – Vancouver, British Columbia, Canada

    Postdoctoral Fellow – Functional Genomics of Lung Cancer

    University of California San Francisco – San Francisco, California, United States

    Postdoctoral Research Scientist – Immunology

    Babraham Institute – Babraham, Cambridgeshire, United Kingdom

    Postdoctoral Positions – Translational 3D Pathology

    University of Washington – Seattle, Washington, United States

    Postdoctoral Research Fellow – Tumor Metabolism

    Wayne State University School of Medicine – Detroit, Michigan, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pulmonary Cell News Twitter